Atlas Trials

Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM)

Clinical trial NCT02570100 · TERMINATED

Trial details

NCT number
NCT02570100
Sponsor
Centre Oscar Lambret
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2015-04-01
Primary completion
2017-07-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.